Mount Sinai released an AI model on April 12, 2026, predicting CPAP therapy's effects on cardiovascular risk for obstructive sleep apnea patients. Nature Medicine reports 93% accuracy.
The model trains on 15,000 patient records from 2018-2025 using XGBoost on polysomnography, oxygen saturation, apnea-hypopnea index, and BMI. It outperforms logistic regression by 22 percentage points. Holdout validation on 5,000 cases identifies 28% risk reductions after six months of CPAP.
Senior author Dr. Indu Ayappa, associate professor at Icahn School of Medicine, said: "It surpasses Framingham and ASCVD scores in precision."
Blockchain Startups License Mount Sinai AI Model
Health tech funding reached $12.4B USD in Q1 2026 (PitchBook). Sleep apnea apps raised $450M USD in 2025 across 18 Series A/B rounds.
SleepChain raised $8M USD seed at $32M USD post-money valuation, led by a16z bio fund, to license the model. CEO Maria Lopez said: "Blockchain verifies CPAP adherence from wearables. Users earn $SLEEP tokens for premium features."
Platforms target 40% of executives with undiagnosed apnea (American Academy of Sleep Medicine, 2025). SleepChain pilots show 22% retention gains over non-blockchain apps. Google's wellness program pairs Oura Ring data with AI via zero-knowledge proofs.
Revenue Models and Data Security
Mount Sinai pilots with ConsenSys Health process 50,000 records daily on Polygon Layer 2. Health dApps captured 18% of DeFi volume in March 2026 (Dune Analytics). Blockchain health tokens rose 15% YTD (CoinMarketCap).
Open-sourced under Apache 2.0, startups fine-tune for Oura/Whoop at $99 USD/month. 100,000 users generate $119M USD ARR at 85% gross margins. FDA Breakthrough Devices enable $500 USD insurer reimbursements via HIPAA-compliant blockchains (UnitedHealth).
Competitors and M&A Activity
ResMed posted $4.2B USD revenue in fiscal 2025 from CPAP sales. It licenses Mount Sinai's model for $2.5M USD annually, boosting software upsell 15%.
South Korea's Medibloc (ICON blockchain) handles 1M records daily; integration lifts throughput 40%. ExecSleep raised $15M USD Series A at $60M USD valuation (Blockchain Capital), using zero-knowledge proofs.
Khosla Ventures predicts $1B USD sleep tech M&A by 2027. Model data shows CPAP adherence cuts stroke risk 42% in one year.
Investment Thesis: Health Blockchain Utility
Crypto shifts to utility; 65% of Fortune 500 leaders track biometrics daily (McKinsey 2026). Salesforce pilots achieve 78% VP uptake, 3:1 ROI, and $1,900 USD absenteeism savings per employee (CDC).
Mount Sinai expands to diabetes models. Blockchain startups target $50B USD wellness market by 2030 (Grand View Research), driving 15% productivity gains (Harvard Business Review).
SleepChain eyes $200M USD ARR by 2028 via licensing. ResMed acquired two AI startups for $300M USD in H1 2026. Adopters gain 25% margin expansion in $10B USD CPAP market. Investors target 5x seed returns.
